RxDoctor Payments DataLook up a doctor →

GAMMAGARD LIQUID: payments to doctors

Payments that named GAMMAGARD LIQUID as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$317K
Providers
174
Transactions
456
Average per transaction
$695

The per-transaction average — $695 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 174 providers the average total is $1,821, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$264,03083.3%
Shire North American Group Inc$52,90816.7%
← All drugs & devices